UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

The New England journal of medicine, 2011-11, Vol.365 (18), p.1673-1683

2011

Volltextzugriff (PDF)

Rapidly Generated Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB17-AB17

2015

Volltextzugriff (PDF)

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma

Cytotherapy (Oxford, England), 2017-03, Vol.19 (3), p.408-418

2017

Volltextzugriff (PDF)

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Blood, 2009-11, Vol.114 (19), p.4283-4292

2009

Volltextzugriff (PDF)

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

Journal of allergy and clinical immunology, 2016-05, Vol.137 (5), p.1498-1505.e1

2016

Volltextzugriff (PDF)

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies

Cytotherapy (Oxford, England), 2021-08, Vol.23 (8), p.694-703

2021

Volltextzugriff (PDF)

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells

Current drug targets, 2017-01, Vol.18 (3), p.271-280

2017

Volltextzugriff (PDF)

Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells

Molecular therapy. Nucleic acids, 2023-06, Vol.32, p.1010-1025

2023

Volltextzugriff (PDF)

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma

Molecular therapy, 2011-12, Vol.19 (12), p.2258-2268

2011

Volltextzugriff (PDF)

Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4

Clinical cancer research, 2011-11, Vol.17 (22), p.7058-7066

2011

Volltextzugriff (PDF)

Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma

Journal of neuropathology and experimental neurology, 2019-05, Vol.78 (5), p.380-388

2019

Volltextzugriff (PDF)

Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes

Cytotherapy (Oxford, England), 2016-12, Vol.18 (12), p.1515-1524

2016

Volltextzugriff (PDF)

Gene Modification of Human Natural Killer Cells Using a Retroviral Vector

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1441, p.203

2016

Volltextzugriff (PDF)

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

Cytotherapy (Oxford, England), 2011-09, Vol.13 (8), p.976-986

2011

Volltextzugriff (PDF)

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

Leukemia & lymphoma, 2010-05, Vol.51 (5), p.870-880

2010

Volltextzugriff (PDF)

T cells as vehicles for cancer vaccination

BioMed research international, 2011-01, Vol.2011 (1), p.417403

2011

Volltextzugriff (PDF)

Low rate of infusional toxicity after expanded cord blood transplantation

Cytotherapy (Oxford, England), 2014-08, Vol.16 (8), p.1153-1157

2014

Volltextzugriff (PDF)

DIPG-58. SUBTYPE-SPECIFIC OVEREXPRESSION OF WILMS’ TUMOR PROTEIN IN PEDIATRIC MIDLINE HIGH GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i60-i61

2018

Volltextzugriff (PDF)

685. Restoration of Antiviral Immunity Following Hematopoietic Stem Cell Transplantation with Virus-Specific T-Lymphocyte Therapy

Molecular therapy, 2016-05, Vol.24, p.S271-S271

2016

Volltextzugriff (PDF)

Low Rate of Infusional Toxicity following Expanded Cord Blood Transplantation

Cytotherapy (Oxford, England), 2014-02, Vol.16 (8), p.1153-1157

2014

Volltextzugriff (PDF)

Improving T cell therapy for relapsed EBV-negative Hodgkin’s Lymphoma by targeting upregulated MAGE-A4

Clinical cancer research, 2011-09, Vol.17 (22), p.7058-7066

2011

Volltextzugriff (PDF)

Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived From HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication

Blood, 2013-11, Vol.122 (21), p.188-188

2013

Volltextzugriff (PDF)

Antigen-Specific Cytotoxic T Lymphocytes can Target Chemoresistant Side-Population Tumor Cells in Hodgkin’s Lymphoma

Leukemia & lymphoma, 2010-05, Vol.51 (5), p.870-880

2010

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorders

Clinical Manual of Blood and Bone Marrow Transplantation, 2017, p.369-375

2017

Volltextzugriff (PDF)

Nanoparticles for Targeting T Cells in Allergy and Inflammatory Airway Conditions

Pulmonary Nanomedicine, 2012, p.159-190

Vij, Neeraj

2012

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(60)
Buchkapitel
(2)

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(37)
Humans
(30)
Medicine, Research & Experimental
(13)
Research & Experimental Medicine
(13)
Hematology
(10)
Biotechnology & Applied Microbiology
(9)
Adolescent
(7)
Adult
(7)
Child
(7)
Female
(7)
Male
(7)
Child, Preschool
(6)
Immunotherapy
(6)
Lymphocytes
(6)
Pharmacology & Pharmacy
(6)
Antigens
(5)
Biological And Medical Sciences
(5)
Cell & Tissue Engineering
(5)
Cell Biology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

Rapidly Generated Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells

Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma

Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4

Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma

Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes

Gene Modification of Human Natural Killer Cells Using a Retroviral Vector

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

T cells as vehicles for cancer vaccination

Low rate of infusional toxicity after expanded cord blood transplantation

DIPG-58. SUBTYPE-SPECIFIC OVEREXPRESSION OF WILMS’ TUMOR PROTEIN IN PEDIATRIC MIDLINE HIGH GRADE GLIOMAS

685. Restoration of Antiviral Immunity Following Hematopoietic Stem Cell Transplantation with Virus-Specific T-Lymphocyte Therapy

Low Rate of Infusional Toxicity following Expanded Cord Blood Transplantation

Improving T cell therapy for relapsed EBV-negative Hodgkin’s Lymphoma by targeting upregulated MAGE-A4

Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived From HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication

Antigen-Specific Cytotoxic T Lymphocytes can Target Chemoresistant Side-Population Tumor Cells in Hodgkin’s Lymphoma

Post-transplant lymphoproliferative disorders

Nanoparticles for Targeting T Cells in Allergy and Inflammatory Airway Conditions

Suchergebnisse filtern